Abstract:In cancer patients, chemotherapeutic medication induces aberrant ROS (reactive oxygen species) accumulation in skeletal muscles, resulting in myofiber degradation, muscle weakness, and even cachexia, which further leads to poor therapeutic outcomes. Acting as an antioxidant, taurine is extensively used to accelerate postexercise muscle recovery in athletes. The antioxidant effects of taurine have been shown in mature myotubes and myofibers but not yet in myoblasts, the myotube precursor. The proliferation and differentiation ability of myoblasts play a very important role in myofiber repair and regeneration, which is usually impaired during chemotherapeutics in cancer patients as well. Here, we explored the effects of taurine supplementation on C2C12 myoblasts exposed to cisplatin-induced ROS. We found that cisplatin treatment led to dramatically decreased cell viability; accumulated ROS level; down-regulated expressions of MyoD1 (myoblast determination protein 1), myogenin, and MHC (myosin heavy chain); and impaired myotube differentiation in myoblasts. Significantly, taurine supplementation protected myoblasts against cisplatin-induced cell viability decrease, promoted cellular ROS clearance, and, most importantly, preserved the expressions of MyoD1, myogenin, and MHC as well as myotube differentiation ability. We further conducted NMR-based metabolomic analysis to clarify the underlying molecular mechanisms. We identified 14 characteristic metabolites primarily responsible for the discrimination of metabolic profiles between cisplatin-treated cells and normal counterparts, including increased levels of BCAAs (branched-chain amino acids: leucine and isoleucine), alanine, glycine, threonine, glucose, ADP (adenosine diphosphate), phenylalanine, and PC (O-phosphocholine), and decreased levels of lysine, β-alanine, choline, GPC (sn-glycero-3-phosphocholine), and myo-inositol. Evidently, taurine supplementation partially reversed the changing trends of several metabolites (isoleucine, threonine, glycine, PC, β-alanine, lysine, and myo-inositol). Furthermore, taurine supplementation promoted the proliferation and myotube differentiation of myoblasts by alleviating cellular catabolism, facilitating GSH (reduced glutathione) biosynthesis, improving glucose utilization and TCA (tricarboxylic acid) cycle anaplerosis, and stabilizing cellular membranes. Our results demonstrated the protective effects of taurine on cisplatin-impaired myoblasts and elucidated the mechanistic rationale for the use of taurine to ameliorate muscle toxicity in clinical chemotherapy cancer patients.

Taurine attenuates gossypol-induced apoptosis of C2C12 mouse myoblasts via the GPR87-AMPK/AKT signaling

Effects of Gossypol on the Proliferation and Apoptosis of Jurkat T Cells

Gossypol Induces Bax/Bak-Independent Activation of Apoptosis and Cytochrome C Release Via A Conformational Change in Bcl-2

Differential Growth Inhibition and Induction of Apoptosis by Gossypol Between Hct116 and Hct116/Bax(-/-) Colorectal Cancer Cells

Molecular Mechanism of Gossypol-Induced Cell Growth Inhibition and Cell Death of HT-29 Human Colon Carcinoma Cells.

A novel role of the mitochondrial permeability transition pore in (-)-gossypol-induced mitochondrial dysfunction

Effect of taurine on cell proliferation and apoptosis human lung cancer A549 cells

Gossypol induces apoptosis in human PC-3 prostate cancer cells by modulating caspase-dependent and caspase-independent cell death pathways.

Cytotoxicity of Malondialdehyde and Cytoprotective Effects of Taurine Via Oxidative Stress and PGC-1α Signal Pathway in C2C12 Cells

Dual Effects of Gossypol on Human Hepatocellular Carcinoma Via Endoplasmic Reticulum Stress and Autophagy.

Natural Bcl-2 inhibitor (−)– gossypol induces protective autophagy via reactive oxygen species–high mobility group box 1 pathway in Burkitt lymphoma

Gossypol induces apoptosis of human pancreatic cancer cells via CHOP/endoplasmic reticulum stress signaling pathway

Taurine Protects C2C12 Myoblasts from Impaired Cell Proliferation and Myotube Differentiation under Cisplatin-Induced ROS Exposure

Involvement of Bcl-2, Src, and ERα in Gossypol-Mediated Growth Inhibition and Apoptosis in Human Uterine Leiomyoma and Myometrial Cells

Suppression of LPS-induced Inflammatory Responses by Gossypol in RAW 264.7 Cells and Mouse Models.

Effects of gossypol on the in vitro proliferation and apoptosis of murine lymphocytes

Gossypol induces apoptosis in ovarian cancer cells through oxidative stress.

Protective Role of Taurine Against Morphine-Induced Neurotoxicity in C6 Cells via Inhibition of Oxidative Stress

Identification of Gossypol Acetate As an Autophagy Modulator with Potent Anti-tumor Effect Against Cancer Cells

The Bcl-2 Homology Domain 3 Mimetic Gossypol Induces Both Beclin 1-Dependent And Beclin 1-Independent Cytoprotective Autophagy In Cancer Cells

Green tea polyphenols inhibit TBBPA-induced lung injury via enhancing antioxidant capacity and modulating the NF-κB pathway in mice